tiprankstipranks
Trending News
More News >
Drug Free Solution (DSOL)
:DSOL
US Market

Drug Free Solution (DSOL) Financial Statements

Compare
9 Followers

Drug Free Solution Financial Overview

Drug Free Solution's market cap is currently $88.89K. The company's EPS TTM is $; its P/E ratio is ―; Drug Free Solution is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 20Jun 19
Income Statement
Total Revenue$ 805.00$ 1.77K
Gross Profit$ 805.00$ -9.23K
Operating Income$ -1.41M$ -1.45M
EBITDA$ -1.39M$ -1.44M
Net Income$ -1.41M$ -1.45M
Balance Sheet
Cash & Short-Term Investments$ 12.50K$ 2.53K
Total Assets$ 52.51K$ 18.05K
Total Debt$ 0.00$ 0.00
Net Debt$ -12.50K$ -2.53K
Total Liabilities$ 333.30K$ 256.30K
Stockholders' Equity$ -280.79K$ -238.25K
Cash Flow
Free Cash Flow$ -419.73K$ -420.30K
Operating Cash Flow$ -382.90K$ -401.50K
Investing Cash Flow$ -36.83K$ -18.80K
Financing Cash Flow$ 429.71K$ 422.83K
Currency in USD

Drug Free Solution Earnings and Revenue History

Drug Free Solution Debt to Assets

Drug Free Solution Cash Flow

Drug Free Solution Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis